Clinical Study
Expression and Prognostic Significance of Wnt7a in Human Endometrial Carcinoma
Table 1
Relationship between the expression of Wnt7a and clinicopathological parameters of endometrial carcinoma.
| Variable | Number | Wnt7a (%) | -value | Negative
| Positive |
| Total | 70 | 44 (62.9)
| 26 (37.1) | | Age (years) | | | | 0.927 | ≤60 | 22 | 14 (63.6)
| 8 (36.4) | | >60 | 48 | 30 (62.5)
| 18 (37.5) | | FIGO stage | | | | 0.001 | I+II | 39 | 18 (46.2)
| 21 (53.8) | | III+IV | 31 | 26 (83.9)
| 5 (16.1) | | Grade | | | | 0.001 | G1 | 30 | 12 (40.0)
| 18 (60.0) | | G2 + G3 | 40 | 32 (80.0)
| 8 (20.0) | | Lymph node metastasis | | | | 0.002 | Negative | 49 | 25 (51.0)
| 24 (49.0) | | Positive | 21 | 19 (90.5)
| 2 (9.5) | | Depth of myometrial invasion | | | | 0.006 | ≤1/2 | 31 | 14 (45.2)
| 17 (54.8) | | >1/2 | 39 | 30 (76.9)
| 9 (23.1) | | LVS involvement | | | | 0.001 | Negative | 44 | 21 (47.7)
| 23 (52.3) | | Positive | 26 | 23 (88.5)
| 3 (11.5) | | Peritoneal cytology | | | | 0.013 | Negative | 53 | 29 (54.7)
| 24 (45.3) | | Positive | 17 | 15 (88.2)
| 2 (11.8) | |
|
|
FIGO: International Federation of Gynecology and Obstertics; LVS: lymph vascular space and *Chi-square test.
|